BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Lone Star Bio

  Molecular Templates Inc. Templates Announces FDA Approval Of Investigational New Drug Application For CD20 Internalizing Immunotoxin MT-3724

  September 8, 2014

   · 

  1 min read
• Policy

  Gilead Sciences, Inc. Release: First-Line Combination Of Ambrisentan And Tadalafil Reduces Risk Of Clinical Failure Compared To Monotherapy In Pulmonary Arterial Hypertension Outcomes Study

  September 8, 2014

   · 

  1 min read
• Business

  PharmAthene, Inc. And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs

  September 8, 2014

   · 

  4 min read
• Drug Development

  Successful Completion Of Phase 3 Program For Teva Pharmaceutical Industries Limited’s Reslizumab Two More Phase Iii Studies Support The Benefits Of Reslizumab Treatment In Asthma Patients With Eosinophilia

  September 8, 2014

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim Corporation Release: TONADO™ - Further Lung Function And Quality Of Life Benefits With Tiotropium + Olodaterol Respimat® FDC* In COPD

  September 8, 2014

   · 

  1 min read
• BioMidwest

  Titan Spine Announces Guarantee For Its Spinal Interbody Fusion Devices

  September 8, 2014

   · 

  1 min read
• Business

  Schrödinger And Tri-Institutional Therapeutics Discovery Institute Announce Agreement To Provide Drug Discovery Software To Tri-Institutional Researchers

  September 8, 2014

   · 

  1 min read
• Pharm Country

  Alexion Pharmaceuticals Inc. Release: Asfotase Alfa Granted Orphan Drug Designation In Japan

  September 8, 2014

   · 

  1 min read
• Genetown

  Charles River Laboratories (Massachusetts) To Present At Morgan Stanley Global Healthcare Conference

  September 8, 2014

   · 

  1 min read
• Drug Development

  Arch Therapeutics Announces Positive Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device™

  September 8, 2014

   · 

  4 min read